DOI: https://dx.doi.org/10.18203/2349-3933.ijam20220427
Published: 2022-02-23

Serum ferritin as a prognostic marker in acute stroke; a cross-sectional observational study

Nidin Mohan, Karthick Murthy, Dayanandan Yoganandan, Kandasamy Venkatraju Rajalakshmi, S. Magesh Kumar

Abstract


Background: Stroke is the leading cause of morbidity and mortality all over the world. Several prognostic factors like site and size of infarction, Glasgow coma scale, level of cerebral edema, intracranial tension have been found significant in stroke. Among the prognostic indicators ferritin has gained importance in recent times. It is considered an acute phase reactant and has been used for assessing the severity and prognosis of stroke. Aim of the study was to correlate the levels of serum ferritin with early neurological status and to predict the severity and prognosis earlier in patients of acute stroke.

Methods: This cross-sectional observational study was done in Saveetha hospital, Chennai. Clinically diagnosed CVA patients within 48 hours of the onset of symptoms were recruited in this study. 122 patients above 18 years who fulfilled the criteria were included and patients with a recent history of inflammation, malignancy, and anemia were excluded.

Results: Around 60.7% of patients had improved and the remaining of them deteriorated. The level of serum ferritin was well correlated with the patient's prognosis. Those who deteriorated had high serum ferritin when compared to those who improved and it was statistically significant.

Conclusions: From our results, we concluded that patients with increased ferritin concentrations have a higher risk of poor clinical outcomes. These findings suggest that iron overload may counterbalance the benefits of thrombolytic therapy in patients with high ferritin levels. Therefore, serum ferritin can be used as a prognostic marker for assessing the severity and prognosis of stroke.


Keywords


Stroke, Ferritin, Prognostic marker

Full Text:

PDF

References


Pankaj P, Das M, Sing MK. Association between level of serum ferritin and outcome of patients of stroke. J Evol Med Dent. 2015;4:2023-36.

Global Health Estimates. Geneva: World Health Organization; 2012. Available at: http://www.who.int/healthinfo/global_burden_disease/en. Accessed on 10 February 2020.

The world health organization MONICA project (monitoring trends and determinants in cardiovascular disease): A major international collaboration. WHO MONICA project principal investigators. J Clin Epidemiol. 1988;41:105-14.

Rådberg JA, Olsson JE, Rådberg CT. Prognostic parameters in spontaneous intracerebral hematomas with special reference to anticoagulant treatment. Stroke. 1991;22(5):571-6.

Van der A DL, Grobbee DE, Roest M, Marx JJ, Voorbij HA, Van der Schouw YT. Serum ferritin is a risk factor for stroke in post-menopausal women. Stroke. 2005;36(8):1637-41.

Njajou OT, Hollander M, Koudstaal PJ, Hofman A, Witteman JC, Breteler MM et al. Mutations in the hemochromatosis gene (HFE) and stroke. Stroke. 2002;33:2363-6.

Millán M, Sobrino T, Arenillas JF, Rodríguez-Yáñez M, García M, Nombela F et al. Biological signatures of brain damage associated with high serum ferritin levels in patients with acute ischemic stroke and thrombolytic treatment. Dis Markers. 2008;25:181-8.

Walters GO, Miller FM, Worwood M. Serum ferritin concentration and iron stores in normal subjects. J Clin Pathol. 1973;26:770-2.

Connor JR, Menzies SL, St Martin SM, Mufson EJ. Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains. J Neurosci Res. 1990;27:595-611.

Walters GO, Miller FM, Worwood M. Serum ferritin concentration and iron stores in normal subjects. J Clin Pathol. 1973;26:770-2.

Connor JR, Menzies SL, St Martin SM, Mufson EJ. Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains. J Neurosci Res. 1990;27:595-611

Orino K, Lehman L, Tsuji Y, Ayaki H, Torti SV, Torti FM et al. Ferritin and the response to oxidative stress. Biochem J. 2001;357:241-7.

Selim MH, Ratan RR. The role of iron neurotoxicity in ischemic stroke. Ageing Res Rev. 2004;3:345-53.

Castellanos M, Puig N, Carbonell T, Castillo J, Martinez J, Rama R et al. Iron intake increases infarct volume after permanent middle cerebral artery occlusion in rats. Brain Res. 2002;952:1-6.

Mehdiratta M, Kumar S, Hackney D, Schlaug G, Selim M. Association between serum ferritin level and perihematomaedema volume in patients with spontaneous intracerebral hemorrhage. Stroke. 2008;39:1165-70.

Xie L, Peng Y, Huang K, Wu Y, Wang S. Predictive value of iron parameters in neurocritically ill patients. Brain Behav. 2018;8(12):e01163.

Selim MH, Ratan RR. The role of iron neurotoxicity in ischemic stroke. Ageing Res Rev. 2004;3:345-53.

Davis S, Helfaer MA, Traystman RJ, Hurn PD. Parallel antioxidant and antiexcitotoxic therapy improves outcome after incomplete global cerebral ischemia in dogs. Stroke. 1997;28:198-204.